Ecthyma gangrenosum: A rare cutaneous manifestation caused by Pseudomonas aeruginosa without bacteremia in a leukemic patient [1]

Indian Journal of Dermatology, Venereology and Leprology

Volumn 71, Issue 2, 2005, Pages 128-129

  Singh, Nabakumar ^a   Devi, Mamta ^a   Devi, Sulochana ^a  

^a REGIONAL INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CYTARABINE; DOXORUBICIN; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANAMNESIS; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL FEATURE; DEBRIDEMENT; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; ECTHYMA GANGRENOSUM; GENERAL CONDITION IMPROVEMENT; GRAM STAINING; HUMAN; LABORATORY TEST; LETTER; MEDICAL EXAMINATION; PSEUDOMONAS AERUGINOSA; SKIN DISEASE; TREATMENT OUTCOME;

EID: 22144447476     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.14002     Document Type: Letter

References (5)

1. Song WK, Kim YC, Park HJ, Cinn YW. Ecthyma gangrenosum without bacteraemia in a leukaemic patient. Clin Exp Dermatol 2001;26:395-7.
2. Dorff GJ, Geimer NF, Rosenthal DR, Rytel MW. Pseudomonas septicemia: Illustrated evolution of its skin lesion. Arch Int Med 1991;128:591-5.
3. Mull JD, Callahan WS. The role of the elastase of Pseudomonas aeruginosa in experimental infection. Exp Mol Pathol 1995;4:567-75.
4. Bottone EB, Reitano M, Janda JM, Troy K, Cuttner J. Pseudomonas maltophilia exoenzyme activity as correlate in pathogenesis of ecthyma gangrenosum. J Clin Microbiol 1996;24:995-7.
5. Young LS, Pollack M. Immunologic approaches to the prophylaxis and treatment of Pseudomonas aeruginosa infection. In: Sabath LD, editor, Pseudomonas aeruginosa, the organism, diseases it causes, and their treatment. Bern: Hans Huber; 1990. p. 119-32.